
### [NCIT:C6813](http://purl.obolibrary.org/obo/NCIT_C6813)
**Label:** Prostate Ductal Adenocarcinoma

**Subclasses:** [NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern), [NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern), [NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern), 

**Class expressions from DL-Learner:**

- Thing 54.08%
- [NCIT:C60531](http://purl.obolibrary.org/obo/NCIT_C60531) (Tall Columnar Adenocarcinoma Cell) 37.28%
- [NCIT:C60531](http://purl.obolibrary.org/obo/NCIT_C60531) (Tall Columnar Adenocarcinoma Cell) and (not ([NCIT:C39597](http://purl.obolibrary.org/obo/NCIT_C39597) (PRKCB Gene))) 37.28%
- [NCIT:C60531](http://purl.obolibrary.org/obo/NCIT_C60531) (Tall Columnar Adenocarcinoma Cell) and (not ([NCIT:C39596](http://purl.obolibrary.org/obo/NCIT_C39596) (CCND2 Gene))) 37.28%
- [NCIT:C60531](http://purl.obolibrary.org/obo/NCIT_C60531) (Tall Columnar Adenocarcinoma Cell) and (not ([NCIT:C39594](http://purl.obolibrary.org/obo/NCIT_C39594) (Skin Rash))) 37.28%
- [NCIT:C60531](http://purl.obolibrary.org/obo/NCIT_C60531) (Tall Columnar Adenocarcinoma Cell) and (not ([NCIT:C39593](http://purl.obolibrary.org/obo/NCIT_C39593) (Peripheral Blood Involvement))) 37.28%
- [NCIT:C60531](http://purl.obolibrary.org/obo/NCIT_C60531) (Tall Columnar Adenocarcinoma Cell) and (not ([NCIT:C39589](http://purl.obolibrary.org/obo/NCIT_C39589) (Angioinvasion))) 37.28%
- [NCIT:C60531](http://purl.obolibrary.org/obo/NCIT_C60531) (Tall Columnar Adenocarcinoma Cell) and (not ([NCIT:C39588](http://purl.obolibrary.org/obo/NCIT_C39588) (Serum Soluble Fas Ligand Level Increased))) 37.28%
- [NCIT:C60531](http://purl.obolibrary.org/obo/NCIT_C60531) (Tall Columnar Adenocarcinoma Cell) and (not ([NCIT:C39586](http://purl.obolibrary.org/obo/NCIT_C39586) (T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta))) 37.28%
- [NCIT:C60531](http://purl.obolibrary.org/obo/NCIT_C60531) (Tall Columnar Adenocarcinoma Cell) and (not ([NCIT:C39584](http://purl.obolibrary.org/obo/NCIT_C39584) (T-Cell Large Granular Lymphocyte Leukemia, Common Variant))) 37.28%
- [NCIT:C60531](http://purl.obolibrary.org/obo/NCIT_C60531) (Tall Columnar Adenocarcinoma Cell) and (not ([NCIT:C39583](http://purl.obolibrary.org/obo/NCIT_C39583) (FAS Apoptosis Pathway Deregulation))) 37.28%
- [NCIT:C60531](http://purl.obolibrary.org/obo/NCIT_C60531) (Tall Columnar Adenocarcinoma Cell) and (not ([NCIT:C3958](http://purl.obolibrary.org/obo/NCIT_C3958) (Disseminated Peritoneal Leiomyomatosis))) 37.28%
- [NCIT:C60531](http://purl.obolibrary.org/obo/NCIT_C60531) (Tall Columnar Adenocarcinoma Cell) and (not ([NCIT:C39573](http://purl.obolibrary.org/obo/NCIT_C39573) (T-Lymphocyte with a Post-Thymic Immunophenotype))) 37.28%
- [NCIT:C60531](http://purl.obolibrary.org/obo/NCIT_C60531) (Tall Columnar Adenocarcinoma Cell) and (not ([NCIT:C39572](http://purl.obolibrary.org/obo/NCIT_C39572) (Neoplastic Cerebriform T-Prolymphocyte))) 37.28%
- [NCIT:C60531](http://purl.obolibrary.org/obo/NCIT_C60531) (Tall Columnar Adenocarcinoma Cell) and (not ([NCIT:C39571](http://purl.obolibrary.org/obo/NCIT_C39571) (Neoplastic Small T-Prolymphocyte))) 37.28%


